Mercado de inmunoterapias para alergias: mapeo competitivo y perspectivas estratégicas para 2031

  • Report Code : TIPRE00008219
  • Category : Pharmaceuticals
  • Status : Published
  • No. of Pages : 149
Buy Now

El mercado de inmunoterapias para la alergia se valoró en 1.819,18 millones de dólares en 2019 y se prevé que alcance los 4.185,89 millones de dólares en 2027; se espera que crezca a una tasa compuesta anual del 11,1% de 2020 a 2027.

La inmunoterapia alérgica, también llamada desensibilización o hiposensibilización, es un tratamiento médico centrado en varios tipos de alergias. Hay un aumento en la prevalencia de alergias y las intervenciones de tratamiento convencionales, como la farmacoterapia, a menudo se han considerado incompetentes. En consecuencia, la inmunoterapia contra la alergia está ganando popularidad para curar varios tipos de alergias al aumentar la tolerancia inmunológica y cambiar el curso de la enfermedad. Se espera que el mercado de inmunoterapias para alergias crezca debido a factores impulsores clave, como la creciente prevalencia de trastornos alérgicos y los avances tecnológicos en las formulaciones de dosificación sublingual. Sin embargo, es probable que los inconvenientes asociados con el uso de inmunoterapias para alergias y las variaciones regulatorias entre regiones obstaculicen el crecimiento del mercado durante el período de pronóstico.

regiones lucrativas para inmunoterapias para alergias Mercado


Perspectivas estratégicas

Perspectivas del mercado

Prevalencia creciente de trastornos alérgicos< /p>

Los trastornos alérgicos son los problemas más comunes abordados por los médicos de atención primaria y pediatras; Más del 25% de la población de los países desarrollados sufre de alergias. Las alergias abarcan un espectro de trastornos que se caracterizan por el desarrollo de una respuesta inmune hiperactiva a un alérgeno, lo que resulta en una respuesta de citoquinas Th2 polarizadas al alérgeno y la producción de una respuesta de anticuerpos IgE.

< p>La creciente prevalencia de trastornos alérgicos exige inmunoterapia para la alergia, que es un tratamiento seguro y eficaz contra alérgenos como el polen, mohos de insectos y animales, así como para el asma alérgica. En el informe reciente de la Encuesta Nacional de Examen de Salud y Nutrición, el 54% de la población tuvo respuestas positivas a uno o más alérgenos. Según la Academia Estadounidense de Alergia, Asma y Enfermedades. Inmunología, la rinitis alérgica afecta entre el 10 y el 30% de la población, y las reacciones adversas a los medicamentos pueden afectar hasta el 10% de la población mundial y casi el 20% de los pacientes hospitalizados. Según los datos de la encuesta del Centro Nacional de Estadísticas de Salud realizada en 2018, el número de alergias respiratorias, alergias alimentarias y alergias cutáneas notificadas en los últimos 12 meses fue de 7,1 millones, 4,8 millones y 9,2 millones, respectivamente.

La inmunoterapia es un tratamiento preventivo para reacciones alérgicas a sustancias como los ácaros del polvo doméstico, el veneno de abeja y el polen de gramíneas. La inmunoterapia implica un aumento gradual de las dosis del alérgeno o sustancia al que el paciente es alérgico. Las dosis incrementales del alérgeno hacen que el sistema inmunológico se vuelva menos sensible a la sustancia, probablemente al inducir la producción de un anticuerpo "bloqueante"; esto reduce los síntomas alérgicos cuando se encuentre la sustancia en el futuro. La inmunoterapia también reduce la inflamación que caracteriza al asma y la rinitis. Los trastornos alérgicos se tratan principalmente con inmunoterapia; por tanto, la creciente prevalencia de enfermedades alérgicas impulsa el crecimiento del mercado.

Información basada en el tratamiento

El mercado global de inmunoterapias para alergias, basado en el tratamiento, se segmenta en inmunoterapia subcutánea (SCIT) e inmunoterapia sublingual (SLIT). En 2019, el segmento de Inmunoterapia Subcutánea (SCIT) tuvo la mayor participación del mercado, por Tratamiento. Sin embargo, se espera que el segmento de inmunoterapia sublingual (SLIT) crezca al ritmo más rápido durante el período de pronóstico.

            ;                           ;                           ;                           ;      

Mercado mundial de inmunoterapias para alergias, por tratamiento– 2019 y 2027

Información basada en el tipo de alergia

El mercado mundial de inmunoterapias para la alergia, según el tipo de alergia, se segmentó en rinitis alérgica, asma, alergia alimentaria, alergia al veneno, y otros. El segmento de rinitis alérgica tuvo la mayor participación en el mercado de inmunoterapias para alergias en 2019, por tipo de alergia. Además, se prevé que el mismo segmento experimente un crecimiento a un ritmo significativo durante el período previsto, de 2020 a 2027.

Información basada en el canal de distribución

El mercado global de inmunoterapias para alergias, según el canal de distribución, se segmenta en farmacia hospitalaria, farmacia minorista y farmacia en línea. En 2019, el segmento de entornos de farmacia hospitalaria tuvo la mayor participación de mercado, por canal de distribución. Además, se espera que el mismo segmento de farmacia crezca al ritmo más rápido durante el período de pronóstico

Las empresas suelen adoptar lanzamientos de productos y estrategias de expansión para expandir su presencia en todo el mundo y satisfacer la creciente demanda. Estas estrategias son comúnmente adoptadas por los actores del mercado para expandir su cartera de productos.

Los actores del mercado que operan en el mercado de inmunoterapias para alergias adoptaron la estrategia de innovación de productos para atender a los clientes cambiantes. demanda en todo el mundo, lo que también permite a los jugadores mantener su marca a nivel mundial.

Por tratamiento

  • Inmunoterapia subcutánea (SCIT)
  • Inmunoterapia sublingual (ITSL)

Por tipo de alergia

  • Rinitis alérgica
  • Asma
  • Alergia alimentaria
  • Alergia al veneno
  • Otros

Por canal de distribución

  • Farmacia hospitalaria
  • Farmacia minorista
  • Farmacia en línea

Por geografía

  • América del Norte
    • EE.UU.
    • Canadá
    • México
  • Europa
    • Francia
    • Alemania
    • < li>Italia
    • Reino Unido
    • España
  • Asia Pacífico (APAC)
    • China
    • India
    • Corea del Sur
    • Japón
    • Australia
  • Oriente Medio y Asia África (MEA)
    • Sudáfrica
    • Arabia Saudita
    • EAU
  • América del Sur (SAM)< ul>
  • Brasil
  • Argentina

Perfiles de empresas

  • ALK-Abelló; A/S
  • AIMMUNE THERAPEUTICS, INC.
  • LETIPharma
  • Stallergenes Greer
  • HAL Allergy BV
  • Johnson y Johnson Services, Inc.
  • Anergis
  • DBV Technologies
  • Dermapharm Holding
  • Terapéutica contra las alergias
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

This text is related
to segments covered.

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

This text is related
to country scope.

Frequently Asked Questions


Who are the major players in the allergy immunotherapies market?

The allergy immunotherapy market majorly consists of the players such as ALK-Abelló A/S, AIMMUNE THERAPEUTICS, INC., LETIPharma, Stallergenes Greer, HAL Allergy B.V., Anergis, DBV Technologies, Dermapharm Holding, Allergy Therapeutics, ASIT biotech are among others.

What are the driving factors for the allergy immunotherapies market across the globe?

The factors that are driving the growth of the market are increasing prevalence of allergic disorders and rising preference for immunotherapies due to efficacy and cost-effectiveness are expected to boost the growth of the global allergy immunotherapy market.

What is allergy Immunotherapy?

Allergy Immunotherapy is an allergy treatment process that involves administering small quantities of allergens into your body and then building up doses slowly over some time until the patient develops immunity. Two types of immunotherapy therapies are available in the market, such as subcutaneous immunotherapy (SCIT), also called allergy shots, and sublingual immunotherapy (SLIT). Individuals with symptoms of allergy and do not respond to conventional medical treatments are the potential targets for allergen immunotherapy.

The List of Companies - Allergy Immunotherapies Market

  1. ALK-Abelló A/S
  2. AIMMUNE THERAPEUTICS, INC.
  3. LETIPharma
  4. Stallergenes Greer
  5. HAL Allergy B.V.
  6. Johnson and Johnson Services, Inc.
  7. Anergis
  8. DBV Technologies
  9. Dermapharm Holding
  10. Allergy Therapeutics

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Related Reports